Correction to Glaxo Sells Rights to Auto-Immune Drug to Novartis
August 21 2015 - 9:26AM
Dow Jones News
GlaxoSmithKline PLC is selling its remaing rights to an
autoimmune disease treatment to Novartis AG. "Glaxa Sells Rights to
Auto-Immune Drug to Novartis," at 0934 GMT, misspelled Glaxo's name
in the headline.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
August 21, 2015 09:11 ET (13:11 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024
